Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
PaperCitations, authors & open-access status
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,273 citations, 2015 year and hybrid oa status.
1,273
Citations
2015
Year
hybrid
OA Status